Global chemicals and ingredients distributor Brenntag delivered double-digit earnings growth in the third quarter of 2026, as stronger commercial execution and aggressive cost-cutting helped counter rising sourcing, energy and logistics costs amid continuing geopolitical uncertainty.
The German-based company reported sales of €4.3 billion for the quarter, up 12.7% year-on-year on a constant currency basis. Operating gross profit increased 10.4% to €1,064 million, while operating EBITDA climbed 14.5% to €385 million.
However, the improvement in earnings came against mounting cost pressures. Brenntag's gross margin slipped 0.6 percentage points to 24.9%, as higher sourcing costs and elevated chemical prices increasingly weighed on gross profit per unit.
The company generated €47 million in cost savings during the quarter through its ongoing cost-out programme, more than offsetting general inflationary cost increases. Higher fuel, freight and energy expenses, however, absorbed part of those gains.
Brenntag attributed its resilience to its global network, broad supplier base and active management of product flows, which helped maintain reliable customer supplies despite disruption to key trade and shipping routes caused by the ongoing Middle East conflict.
Jens Birgersson, Chief Executive Officer of Brenntag SE, said: “The third quarter came in line with our expectations, with earnings growing again in a volatile and uncertain market. Conditions remain fragile, with inflation and elevated energy, transportation and freight costs continuing to weigh on our business. The unusually supportive pricing environment we saw in the second quarter did not persist in Q3. That is why this result matters: the underlying improvements in our business are holding.
"We grew operating gross profit and operating EBITDA organically in both divisions, across most Essentials regions and in both Specialties segments.
"What we report today gives us confidence that the actions we have taken are beginning to translate into lasting operational and financial improvement. But much remains to be done, and at our Capital Markets Day tomorrow we will set out how we intend to build on this progress.”
Brenntag's operating EBITDA conversion ratio improved 1.3 percentage points to 36.2%, while volumes remained broadly stable.
Its cost-out programme delivered cumulative savings of approximately EUR 115 million in the first nine months of 2026. The company remains on track to generate around €150 million in gross savings for the full year.
Thomas Reisten, Chief Financial Officer of Brenntag SE, said: “Our cost-out program contributed EUR 47 million in savings during the quarter, bringing cumulative savings to around EUR 115 million in the first nine months, and we are on track to deliver approximately EUR 150 million of gross savings this year. Based on the continued positive development in the third quarter, we confirm our operating EBITDA outlook of EUR 1,350 million to EUR 1,450 million for the full year 2026 and expect a result towards the upper end of this range.”
Free cash flow, however, fell to €183 million from €315 million in the corresponding quarter last year. The decline reflected an EUR 88 million working capital outflow, compared with an inflow of €97 million a year earlier, as elevated prices increased working capital requirements.
Both of Brenntag's divisions delivered higher operating gross profit and EBITDA, with Essentials emerging as the stronger contributor.
Brenntag Essentials posted operating gross profit of €765 million, up 12.4%, while operating EBITDA rose by the same percentage to €276 million. Its gross margin declined 0.9 percentage points to 25.8%.
North America led regional growth, with operating gross profit surging 15.6% and operating EBITDA increasing 18.4%.
EMEA also delivered gains, with operating gross profit rising 9.8% and EBITDA growing 5.5%. In Asia-Pacific (APAC), operating gross profit increased 5.6%, while EBITDA advanced 8.7%, despite pressure on volumes.
Latin America proved the exception. While operating gross profit increased 7.9%, EBITDA declined 4.9%, hit by the earthquake in Colombia, exceptional input cost increases in Mexico that affected demand, and higher transportation expenses.
Brenntag Specialties reported operating gross profit of €299 million, up 5.4%, while operating EBITDA increased 2.5% to €110 million. Its gross margin improved marginally by 0.1 percentage points to 23%.
Material Science was the standout performer, with operating gross profit climbing 8.8% and EBITDA increasing 13.3%, supported by selected lubricants and performance materials.
Life Science recorded more moderate growth, with operating gross profit up 3.5% and EBITDA rising 1.4%. Beauty & Personal Care delivered strong volume growth, while Pharma benefited from improving sequential gross profit per unit trends.
Brenntag said its commercial initiatives and organisational restructuring continued to strengthen operational performance across the Group.
Organic operating gross profit per working day increased in the third quarter, even after adjusting for the impact of the Middle East conflict.
The company also expanded supplier partnerships in Beauty & Personal Care and Pharma and opened a new Nutrition Innovation & Application Center in Jakarta in September.
In EMEA, Brenntag continued streamlining its organisational structure, cutting overheads and clarifying responsibilities to improve operational accountability.
Its acquisition strategy also gained momentum. At the end of October, the company completed the acquisition of Woojin Trading, a South Korean distributor of specialty ingredients for the beauty and personal care industries.
The deal strengthens Brenntag's position in South Korea's growing beauty and personal care market. Meanwhile, the integration of the Airedale Group, acquired in February 2026, and Chem Tech is progressing as planned.
Brenntag maintained its full-year 2026 operating EBITDA guidance of €1.35 billion to €1.45 billion, with earnings now expected towards the upper end of the range.
The outlook assumes no broad-based deterioration in customer demand across its end markets. However, the company warned that the fourth quarter is likely to face subdued global demand, geopolitical uncertainty and moderate but volatile inflationary pressures.
The Middle East conflict remains a key risk, with potential disruption to energy supplies, shipping routes and global trade flows threatening supply chains, raw material prices and economic growth.
Brenntag will outline its medium-term strategy, evolving operating model and long-term value creation plans at its Capital Markets Day on November 12, 2026.
The third-quarter performance marks further progress in the company's earnings recovery, but the challenge now is to sustain growth as cost pressures, geopolitical instability and uncertain demand continue to test the global chemicals distribution industry.
